HLD Europe has completed the sale of a 9.77% stake in Exosens to THEON INTERNATIONAL for €54 per share, while retaining a 22.35% interest.
Information on the Target
Exosens is a prominent player in the optical technology sector, specializing in advanced imaging systems and night vision products. With a robust portfolio, the company has made significant strides in delivering cutting-edge solutions for defense and security applications.
Founded with a vision to innovate in the field of optronics, Exosens has garnered a reputation for its commitment to quality and performance. The recent stake sale marks a shift in its ownership structure while allowing room for strategic partnerships that could enhance its market position.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The optical technology industry in France has been experiencing robust growth, driven by increasing demand for high-precision imaging solutions. The se
Similar Deals
Antoine Carrette (soutenu par IRD INVEST) → CUPPENS
2025
THEON INTERNATIONAL
invested in
Exosens
in 2026
in a Other deal
Disclosed details
Transaction Size: $10M